Wockhardt Share Price: Shares of pharmaceutical company Wockhardt have skyrocketed over 30 per cent in just two days. Volumes at its counter have also seen a major spurt in the two sessions.
On Tuesday, July 2, the pharma stock jumped 8.88 per cent to hit a new 52-week high of Rs 897.10 apiece on NSE. The stock on Monday, July 1 shot up 20 per cent to hit the upper circuit.
Around the time of filing this report, the stock's last traded price was Rs 858.05 apiece, up 4.14 per cent. So far over 41.4 lakh shares have changed hands on the counter. On Monday, July 1, the counter saw 62,33,251 shares changed hands.
This marked the first instance in the US, where Zaynich had been used to combat a complex infection caused by extreme-drug-resistant pseudomonas, the company said.
"Till recently, the patient was in severe pain and faced mobility challenges and pressure ulcers at various areas of skin with inflammation. The infecting pathogen was a metallo-β-lactamase-harbouring Pseudomonas aeruginosa, which is one of the toughest resistance mechanisms known. After 2 weeks of Zaynich (Zidebactam/Cefepime- WCK 5222) treatment, the thigh wound beds started looking healthy with diminished bacterial load, and xenograft placement could be undertaken. Eventually, the abdominal wound completely healed and bilateral thigh wounds fully incorporated the graft. After 4 weeks of Zaynich treatment, since the wounds appeared healed, no cultures were taken. Zaynich (Zidebactam/Cefepime- WCK 5222) was well-tolerated by the patient during the 4-week treatment," Wockhardt's press release stated.
"In this backdrop, the uptrend seen recently is sustainable in the long-term."
(Disclaimer: The above article is meant for informational purposes only, and should not be considered as any investment advice. ET NOW DIGITAL suggests its readers/audience to consult their financial advisors before making any money related decisions.)
2024-07-02T09:34:48Z dg43tfdfdgfd